10/08/2017
Novartis announces AMG 334 significantly reduces patients’ monthly migraine days in phase II study of chronic migraine prevention

Phase II 20120295 study of AMG 334 met primary endpoint, confirming efficacy and safety in patients with chronic migraine over 12 weeks of treatment M...

Read More

03/08/2017
Cluster Headache

Often called 'suicide headaches', around 130,000 people in the UK suffer from the debilitating condition, cluster headaches. They are excruciating att...

Read More

10/07/2017
Cluster Headache vs. Migraine

Cluster headaches and migraines both cause pain, but they are two different conditions. A cluster headache is a headache that occurs several times in...

Read More

02/07/2017
Migraine at work -Questions

Frequently asked questions Is migraine a disability? What rights do I have at work? It may be – the answer depends upon your own individual circumst...

Read More

01/07/2017
Positive Phase III data for migraine drug Fremanezumab

Positive results from a Phase III HALO study of fremanezumab, an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody investigational treat...

Read More

05/06/2017
Under the hat

The European Headache Federation (EHF) and the European Headache Alliance (EHA) are pleased to announce the 21st March as the first Cluster Headache D...

Read More

10/05/2017
One Tough Challenge: Motherhood with Migraines

Let me set the scene: a Monday evening in late January. My husband had been working like a dog for over a week and I had barely seen him in days. The...

Read More

10/04/2017
The results of greater occipital nerve block applied for migraine headache

OBJECTIVES: The aim of this study was to evaluate the efficacy of greater occipital nerve (GON) block in the treatment of migraine patients. METHODS:...

Read More

10/03/2017
Disability & Catastrophizing In Chronic Migraine vs Temporomandibular Disorder

Patients with chronic migraine share features with individuals with temporomandibular disorders that include kinesiophobia and neck disability, accord...

Read More

10/02/2017
Marking 50 years of spinal cord stimulation

The year 2017 marks the 50th anniversary for spinal cord stimulation therapy which was first used to treat pain in 1967. To celebrate the occasion, N...

Read More
Novartis announces AMG 334 significantly reduces patients’ monthly migraine days in phase II study of chronic migraine prevention
Phase II 20120295 study of AMG 334 met primary end...
Cluster Headache
Often called 'suicide headaches', around 130,000 p...
Cluster Headache vs. Migraine
Cluster headaches and migraines both cause pain, b...
Migraine at work -Questions
Frequently asked questions Is migraine a disabilit...
Positive Phase III data for migraine drug Fremanezumab
Positive results from a Phase III HALO study of fr...
Under the hat
The European Headache Federation (EHF) and the Eur...
One Tough Challenge: Motherhood with Migraines
Let me set the scene: a Monday evening in late Jan...
The results of greater occipital nerve block applied for migraine headache
OBJECTIVES: The aim of this study was to evaluate...
Disability & Catastrophizing In Chronic Migraine vs Temporomandibular Disorder
Patients with chronic migraine share features with...
Marking 50 years of spinal cord stimulation
The year 2017 marks the 50th anniversary for spina...
Home 2017-07-19T12:26:14+00:00

All EHA Members

EHA Calendar

What is EHA?

The European Headache Alliance is a non-profit, patient umbrella group which was launched in 2006. Since then, the Alliance has grown to represent 25 patient groups from across the continent.

The development of European umbrella organisations is a natural progression with more relevance for European nations.

Read More

About Headache

Headache disorders are among the most common disorders of the nervous system. These include tension-type headache (TTH), migraine and chronic daily headache syndromes as well as the more rare disorders, cluster headache and trigeminal neuralgia.

Read More

datas
EHA Data charts

Statistical data

In 2010, EHA launched its Madrid Manifesto for Migraine/ Headache Disorders at the Spanish Parliament to mark European Migraine Day of Action. This document outlined our 5-year objectives to improve migraine management, education and awareness across Europe.

Projects

EHA is the result of the need of making society know the different types of migraine that exist and that currently are not receiving the importance they deserve. EHA fights for the human rights, that is why is present in activities and events that are relevant for headache issues. Trying to give voice for those ones who need it. EHA works as well in finding a way to mitigate migraine, by joining forces and strengthening partnerships which are aiming the same objective.

Utilizamos cookies propias y de terceros para el correcto funcionamiento del portal y de sus complementos, reproducir conteido multimeda, interactuar con redes sociales y realizar analíticas de navegación. Si continúas navegando aceptas el uso de dicha tecnología, para más información visita nuestra política de cookies. Find out more

Los ajustes de cookies de esta web están configurados para "permitir cookies" y así ofrecerte la mejor experiencia de navegación posible. Si sigues utilizando esta web sin cambiar tus ajustes de cookies o haces clic en "Aceptar" estarás dando tu consentimiento a esto.

Cerrar